CIDP pursues its endeavours to give NAFLD and NASH patients access to treatment !

As we marked the International NASH Day last week, our CIDP Pharma community comes together to reiterate its commitment to alleviate the sufferings of the countless people afflicted with the disease.

More closer to home, NASH remains a growing health challenge for many African countries, including Mauritius, which has been battling several chronic diseases, including diabetes and obesity. It is important to emphasize that NASH is a progressive disease. With no clear symptoms in the early stages of the disease, diagnosis can be missed until it has progressed to an advanced stage.

As part of our focus on fighting metabolic disease, CIDP continues its efforts in seeking alliance with world leaders striving to find a cure for NASH.